anastrozole and calcipotriene

anastrozole has been researched along with calcipotriene in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Anisiewicz, A; Chodyński, M; Filip-Psurska, B; Kutner, A; Libako, P; Maciejewska, M; Psurski, M; Wietrzyk, J; Zbrojewicz, E	1

Other Studies

2 other study(ies) available for anastrozole and calcipotriene

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models. International journal of molecular sciences, 2021, Mar-09, Volume: 22, Issue:5 Topics: Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Calcitriol; Dihydroxycholecalciferols; Female; Humans; MCF-7 Cells; Mice; Mice, SCID; Xenograft Model Antitumor Assays	2021

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models.

International journal of molecular sciences, 2021, Mar-09, Volume: 22, Issue:5

Topics: Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Calcitriol; Dihydroxycholecalciferols; Female; Humans; MCF-7 Cells; Mice; Mice, SCID; Xenograft Model Antitumor Assays

2021